U.S. Cancer Screening Trial Shows No Early Mortality Benefit from Annual Prostate Cancer Screening
Six annual screenings for prostate cancer led to more diagnoses of the disease, but no fewer prostate cancer deaths, according to a major new report from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. The Lombardi Comprehensive Cancer Center at Georgetown University Medical Center is one of the 10 sites that enrolled participants onto this trial. The PLCO was designed to provide answers about the effectiveness of prostate cancer screening.
“While this report tells us that prostate cancer screening works in terms of finding and diagnosing the disease we’re discovering that these diagnoses don’t necessarily equate to lives saved,” says Claudine Isaacs, MD, principal investigator of the Lombardi PLCO study site.
Free Prostate Cancer Lecture - November 12, 2008
The Prostate Center at the Lombardi Comprehensive Cancer Center is a multidisciplinary clinic where physicians and scientists interact to advance state-of-the-art treatment of patients with the goal of curing prostate cancer and maximizing quality of life. Please join us for an informative, interactive discussion about prostate cancer on Wednesday, November 12, 2008. in the Leavey Conference Center at the Georgetown University Hospital. Attendance is free but registration is required.
